Reply  by Min, James K. et al.
Rt
C
s
a
i
c
a
p
R
5
6
7
8
701JACC Vol. 59, No. 7, 2012 Correspondence
February 14, 2012:699–701were found to have either 2- or 3-vessel CAD when assessed by
using CCTA.
Using scores from the screening coronary calcium CT scan, the
patients can similarly be divided into the 10% with the highest
absolute coronary calcium scores, the 13% of the patients with the
next highest scores, followed by the next 34% of the patients, and
finally the remaining approximately 43% of patients with no
calcium present (or very low calcium scores).
The same Kaplan-Meier analysis can then be applied to these
groups separated on the basis of their absolute coronary calcium
score (assuming that score is available). If these groups, when
separated on the basis of the calcium scores, stratify mortality
outcomes as well as the CCTA results for the number of vessels
with coronary stenosis, this would be useful information.
A much less expensive test that imparts considerably less
radiation can then be used to help assess future mortality. In
addition, regardless of the result, this would represent additional
information regarding how much coronary artery stenosis plays a
role in mortality prognosis beyond total coronary plaque burden.
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Reply
We thank Dr. Roehm for his comments addressing our findings
from the CONFIRM registry (1). He questioned whether the
prognostic value of coronary artery disease stenosis severity by
using coronary computed tomography angiography (CCTA) is
additive to findings provided by noncontrast coronary artery
calcium scoring (CACS). This distinction is of high importance
and relates to whether stenosis or plaque detection is most germane
for clinical risk prediction.
Previous population studies have demonstrated significant im-
provement in risk stratification by CACS beyond clinical risk factors,
and CACS is now considered reasonable for asymptomatic adults at
10% to 20% 10-year risk of events (2,3). In contrast, CCTA has
generally been used for symptomatic individuals for detection or
exclusion of coronary stenosis, and current American College of
Cardiology Foundation Appropriate Use Criteria are in keeping with
this practice (4). CCTA is safe, with significant improvements in
echnology now allowing performance with radiation doses similar to
ACS (5). To date, the differential prognostic utility of CCTA
tenosis and CACS has been inadequately explored.
One additional benefit of CCTA is its ability to assess other
therosclerotic plaque characteristics (APCs). Recent CCTA stud-
es have examined plaque features that are only visualized by
ontrast enhancement and include low attenuation plaque, positive
rterial remodeling, and admixtures of noncalcified and calcified
laque (6,7). These investigations have denoted a prognosticimportance for APCs, both for myocardial ischemia and acute
coronary syndromes. Although quantitative assessment of APCs is
currently time-intensive, novel validated software now offers an
automated method for comprehensive characterization of stenosis,
calcified plaque, and other APCs (8).
Evaluation of the incremental significance of CCTA findings is
vital and should entail not only descriptions of calcified plaque but
also the entirety of APCs important to coronary events. This
evaluation within the CONFIRM registry is ongoing.
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